Milind Deshpande

Insider Reports History

Location
New Haven, CT
Signature
/s/ Maegan Deare, Attorney-in-Fact for Milind Deshpande
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Milind Deshpande:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 91,454 $66,761 $0.7300 12 Jun 2025 Direct

Insider Reports Filed by Milind Deshpande

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 20:30
SPRO Spero Therapeutics, Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 16:29
SPRO Spero Therapeutics, Inc. 05 Oct 2023 1 $0 4 Director 10 Oct 2023, 17:34
SPRO Spero Therapeutics, Inc. 15 Sep 2022 1 $0 4 Director 19 Sep 2022, 17:44
SPRO Spero Therapeutics, Inc. 17 Aug 2021 1 $0 4 Director 18 Aug 2021, 16:56